Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Retrospective analysis of different rabbit ATG brands on outcome and occurrence of acute and chronic GVHD in patients with aplastische anemia undergoing allogeneic transplantation

Retrospective Studies

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Allogeneic - Related

Allogeneic - Unrelated

Investigateur principal

Outcome of transplant in PNH patients treated after 2011

Études rétrospectives

Aplasie Médullaire

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Investigateur principal

Transplant outcomes in patients over 40 years old with severe aplastic anemia (SAA) treated after 2010

Retrospective Studies

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Investigateur principal

Antonio Risitano

Résultats de la greffe chez les patients atteints d'aplasie médullaire sévère (SAA) âgés de plus de 40 ans et traités après 2010

Études rétrospectives

Aplasie Médullaire

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Investigateur principal

Antonio Risitano

Allogeneic Hematopoietic Stem Cell Transplantation for ERCC6L2 disease

Aplasie Médullaire

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Investigateur principal

Ulla Wartiovaara-Kautto, Outi Kilpivaara and Flore Sicre de Fontbrune

Allogeneic HSCT in ICU setting

Aplasie Médullaire

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Investigateur principal

Tayfun Güngör

Post-transplant cyclophosphamide as GvHD prophylaxis in patients with aplastic anemia with different donors: a comparative study of the SAAWP EBMT

Études rétrospectives

Aplasie Médullaire

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Investigateur principal

Renal failure in aplastic anemia

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Investigateur principal

Beatrice Drexler

Outcomes of treatment with anti thymocyte globulin (ATG) for acquired pure red cell aplasia

Retrospective Studies

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Investigateur principal

RACE-2: long-term follow-up of patients participating in RACE: the prospective Randomized multicenter study comparing horse Antithymocyte globuline (hATG) + Cyclosporine A (CsA) with or without Eltrombopag as front-line therapy for Severe Aplastic Anemia patients

Non-interventional Prospective Studies

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Immunosuppressive Treatment (IST)

Investigateur principal

Régis Peffault de Latour, Antonio M. Risitano

Clonal evolution in acquired aplastic anemia

Retrospective Studies

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Investigateur principal

Pedro de Lima Prata